Serum myeloid-related protein 8/14 complex is associated with microalbuminuria in patients with type 2 diabetes

Christoph Schmaderer1, Stephan Kemmner2, Klaus Burkhardt3

  • 1Department of Nephrology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675 Munich, Germany christoph.schmaderer@lrz.tum.de.

Abstract

Insights

Microalbuminuria (MA) in type 2 diabetes patients is linked to higher levels of myeloid-related protein 8/14 (MRP8/14), indicating macrophage activation. This suggests inflammation plays a role in the increased cardiovascular risk associated with MA.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Background:

  • Microalbuminuria (MA) is an independent predictor of cardiovascular risk and renal disease progression in diabetic patients.
  • MA is linked to microvascular defects and inflammation, with activated macrophages playing a key role.
  • Myeloid-related protein 8/14 complex (MRP8/14) is secreted by transmigrating macrophages.

Purpose of the Study:

  • To investigate the association between microalbuminuria (MA) and elevated myeloid-related protein 8/14 (MRP8/14) levels in patients with type 2 diabetes.
  • To determine if MA predicts MRP8/14 levels, suggesting macrophage activation in diabetic cardiovascular risk.

Main Methods:

  • 86 men with type 2 diabetes were categorized into normoalbuminuria and MA groups.
  • Serum MRP8/14 levels were quantified using enzyme-linked immunosorbent assay.
  • Cardiovascular risk factors were assessed and compared between groups.

Main Results:

  • Albuminuria showed a positive correlation with MRP8/14 levels (r = 0.34) and systolic blood pressure (r = 0.33).
  • Patients with MA had significantly higher MRP8/14 levels compared to those with normoalbuminuria.
  • MA independently predicted higher MRP8/14 levels, systolic blood pressure, and hemoglobin A1c.

Conclusions:

  • Albumin excretion is associated with macrophage activation, as indicated by MRP8/14 levels.
  • These findings suggest tissue inflammation and macrophage activation contribute to elevated cardiovascular risk in type 2 diabetes.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17